BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT03000075 · COMPLETED
Trial details
- NCT number
- NCT03000075
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-02
- Primary completion
- 2017-09-21
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.